Anika Therapeutics, Inc.ANIKNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Percentile
P0
Near historical low
vs 3Y Ago
-0.2x
Contraction
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM-3.62%-243.9%
20242.52%-79.8%
202312.47%-21.8%
202215.95%+666.3%
2021-2.82%-266.0%
2020-0.77%-102.2%
201935.11%+34.0%
201826.20%-40.6%
201744.10%-16.1%
201652.56%-